HARMONY
A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus.
- Stage
- klaar
- Medicine
- albiglutide
- Population
- Diabetes Mellitus
- Phase
- III
- First Patient In
- 15 August 2015
- Last Patient In
- 28 November 2016
- Last Patient Last Visit
- 28 February 2018
National Lead
prof. dr. J.H. Cornel
Cardioloog
Study Director
